A recent study found that while treatment outcomes for a CLL therapy are comparable in clinical trials and the real-world setting, adverse events are increased in the latter. READ MORE

Research in Review

Single-agent blinatumomab demonstrated antileukemia activity in pediatric patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia, according to a study published in the Journal of Clinical Oncology.

READ MORE

Patients with chronic myeloid leukemia and a history of prior malignancies appear to have the same outcomes as patients with no prior malignancies, according to a study published in Cancer. 

READ MORE

Researchers may have found a cost-efficient way of examining individual leukemia cells, which could transform treatment strategies and make care more personalized.

READ MORE